Most Recent
A unit of Fortescue Metals Group has won its bid for emails between Squire Patton Boggs and a unit of electricity provider TransAlta Energy relating to a disputed power purchase agreement, saying privilege was waived when the emails were forwarded to a third party.
A Melbourne cafe embroiled in a Fair Work battle over alleged staff underpayments has now been hit with a $185,000 fine for copyright infringement in a separate case brought against it by the Phonographic Performance Company of Australia.
The Australian Maritime Safety Authority has convinced a Federal Court judge that 90 tonnes of oil spilled near the Great Barrier Reef in 2015 came from a vessel operated by international shipping company Globex.
A Federal Court judge has expressed her disbelief at a cross claim by generic drug maker Sandoz against Danish multinational H Lundbeck, as the court begins to weigh arguments over damages owed to Lundbeck in the long-running patent case over its blockbuster anti-depressant Lexapro.
The ACCC has opened an inquiry into the inordinately high exchange fees consumers face when sending money outside Australia.
Take-Two interactive has won an injunction blocking a Grand Theft Auto gamer from distributing software that allows users to access restricted features of the popular game, a month after reaching a settlement with a gamer in a separate copyright case.
Investment manager Blue Sky, which is currently facing three shareholder class action investigations, has admitted to incorrectly charging $4.1 million in fees to certain funds over a ten-year period.
Telstra customers that were billed for mobile phone apps they unwittingly bought have been refunded $9.3 million, several months after the company was hit with a $10 million penalty for the misleading conduct.
Preparations for a December trial between Merck Sharp & Dohme Corporation and Wyeth over four patents for the pneumococcal disease vaccine are underway, and a panel of experts will feature prominently in the high-stakes hearing over the world's best-selling vaccine.
Shareholders in a class action against Sirtex have secured an order forcing the life sciences company to notify them of any plan that would see its $128 million in liquid assets drop below $80 million.